Due to transition in the journal platform, the previously submitted articles, which are under process can be re-submitted here for quick process, kindly co-operate


Volume: 44 Issue: 1

  • Open Access
  • Original Article

Idiopathic sudden sensorineural hearing loss: A trial of modified Stennert’s infusion therapy


 Rukma Bhandary1, Mahesh S. G.1, Sapna M.1, Abhishek Sharma


1Department of Otorhinolaryngology, A. J. Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India 

2Consultant ENT Surgeon, Sahara hospital, Lucknow, Uttar Pradesh, India 


 Corresponding author: Mahesh S.G. Email: [email protected] 

Year: 2024, Page: 131-135, Doi: https://doi.org/10.51248/.v44i1.4038

Received: Nov. 1, 2023 Accepted: Feb. 11, 2024 Published: May 1, 2024



 Introduction and Aim: Sudden sensorineural hearing loss presents as rapid onset hearing deterioration of more than 30dB within 72 hours at the minimum of three adjacent frequencies. The aim of this research was to determine the effect of Modified Stennert’s Protocol in addressing idiopathic sudden sensorineural hearing loss. 

Materials and Methods: Retrospective pilot study was done. 14 patients were started on Modified Stennert’s protocol within 72 hours of onset of symptoms and were observed. Our modification included using hydrocortisone instead of prednisolone. 

Results: All patients presenting with sudden sensorineural hearing loss showed significant improvement in hearing by the end of two weeks and at the end of 3 months. 

Conclusion: With such obscured pathophysiology, treatment of modified versions of usage of hydrocortisone instead of prednisolone along with dextran and pentoxyfylline has shown prime augmentation towards the patients resulting in near normal hearing. 

Keywords: Sensorineural hearing loss; idiopathic, Stennert’s protocol; hydrocortisone; dextran; pentoxyfylline



  1. Watkinson, J.C., Clarke, R.W. Scott-Brown’s otorhinolaryngology and head and neck surgery. Volume 2, Paediatrics, the ear, and skull base surgery. Milton: Chapman and Hall/CRC; 2018.739-743. 
  2. Kuhn, M., Heman-Ackah, S.E., Shaikh, J.A, Roehm, P.C. Sudden sensorineural hearing loss: A review of diagnosis, treatment, and prognosis. Trends Amplif. 2011;15(3):91-105. 
  3. Jeong, J., Choi, H.S. Sudden sensorineural hearing loss after COVID-19 vaccination. International Journal of Infectious Diseases. 2021;113:341-343. 
  4. Mahesh, S.G., Nayak, D.R., Balakrishnan, R., Pavithran, P., Pillai, S., Sharma, A. Modified Stennert’s Protocol in treating acute peripheral facial nerve paralysis: Our experience. Indian J Otolaryngol Head Neck Surg. 2013;65(3):214-218. 
  5. Kinishi, M., Amatsu, M., Hosomi, H. Conservative treatment of Bell’s palsy with steroids and dextran-pentoxiphylline combined therapy. Eur Arch Otorhinolaryngol. 1991;248(3): 147-149. 
  6. Wang, C., Chou, H., Fang, K., Lai, M., Cheng, P. Treatment outcome of additional dextran to corticosteroid therapy on sudden deafness: Propensity score–matched cohort analysis. Otolaryngol-head neck Surg. 2012;147(6):1125-1130. 
  7. Wei, B.P., Stathopoulos, D., O’Leary, S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane ENT Group, editor. Cochrane database of systematic reviews. 2013 Jul 2 [cited 2024 Feb 4]. 
  8. Reisser, C.,H., Weidauer, H. Ginkgo biloba extract EGb 761 or pentoxifylline for the treatment of sudden deafness: a randomized, reference-controlled, double-blind study. Acta Otolaryngol. 2001;121(5):579-584. 
  9. Beckers, E., Chouvel, P., Cassetto, V., Mustin, V. Sudden sensorineural hearing loss in COVID‐19: A case report and literature review. Clinical Case Reports. 2021;9(4):2300-2304. 
  10. Hultcrantz, E., Nosrati-Zarenoe, R. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: analysis of an RCT and material drawn from the Swedish national database. Eur Arch Otorhinolaryngol. 2015;272(11):3169-3175. 
  11. Leung, M.A., Flaherty, A., Zhang, J.A., Hara, J., Barber, W., Burgess, L. Sudden sensorineural hearing loss: Primary care update. Hawaii J Med Public Health. 2016;75(6):172-174. 
  12. Shah, S., Rocke, J., France, K., Izzat, S. Sudden sensorineural hearing loss in COVID-19: A case series from the Wrightington, Wigan and Leigh Teaching Hospitals, United Kingdom. Med J Malaysia. 2021;76(Suppl 4):55-59. 
  13. Lan, W., Wang, C., Lin, C. Pentoxifylline versus steroid therapy for idiopathic sudden sensorineural hearing loss with diabetes. J Int Adv Otol. 2018;14(2):176-180. 
  14. Fujimura, T., Suzuki, H., Shiomori, T., Udaka, T., Mori, T. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2007; 264(8):861-866. 
  15. Zadeh, M.H., Storper, I.S., Spitzer, J.B. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg. 2003;128(1):92-98. 

Cite this article


Rukma Bhandary, Mahesh S. G, Sapna M. Abhishek Sharma2 Idiopathic sudden sensorineural hearing loss: A trial of modified Stennert’s infusion therapy.  Biomedicine: 2024; 44(1): 131-135.